Long-term outcomes of prolonged bisphosphonates more than 2 years in bone metastatic breast cancer: risk vs benefit
IRISH JOURNAL OF MEDICAL SCIENCE (2020)
Journal
IRISH JOURNAL OF MEDICAL SCIENCE
Volume 189, Issue 3, Pages 805-810Publisher
SPRINGER LONDON LTD
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study
Hironobu Hata, Kenji Imamachi, Michihiro Ueda, Masashi Matsuzaka, Hiroaki Hiraga, Toshihisa Osanai, Toru Harabayashi, Katsuya Fujimoto, Satoshi Oizumi, Masato Takahashi, Kazuhito Yoshikawa, Jun Sato, Yutaka Yamazaki, Yoshimasa Kitagawa
SUPPORTIVE CARE IN CANCER (2022)
The Role of the Immune Response in the Development of Medication-Related Osteonecrosis of the Jaw
Weidong Zhang, Ling Gao, Wenhao Ren, Shaoming Li, Jingjing Zheng, Shasha Li, Chunmiao Jiang, Shuying Yang, Keqian Zhi
FRONTIERS IN IMMUNOLOGY (2021)
Dietary nitrate improves jaw bone remodelling in zoledronate-treated mice
Wen Pan, Jianyu Gu, Shihan Xu, Chunmei Zhang, Jinsong Wang, Songlin Wang, Junji Xu
CELL PROLIFERATION (2023)
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS
Athanasios D. Anastasilakis, Jessica Pepe, Nicola Napoli, Andrea Palermo, Christos Magopoulos, Aliya A. Khan, M. Carola Zillikens, Jean-Jacques Body
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Association between Hyperglycemia and Medication-Related Osteonecrosis of the Jaw (MRONJ)
Gabor Kammerhofer, Daniel Vegh, Dorottya Banyai, Adam Vegh, Arpad Joob-Fancsaly, Peter Hermann, Zoltan Geczi, Tamas Hegedus, Kata Sara Somogyi, Bulcsu Bencze, Zita Biczo, Donat Huba Juhasz, Peter Zaborszky, Marta Ujpal, Mihaly Tamas Vaszilko, Zsolt Nemeth
JOURNAL OF CLINICAL MEDICINE (2023)
Medication-Related Osteonecrosis of the Jaw-A Continuing Issue
Krzysztof Wrobel, Maciej Sikora, Maciej Checinski, Maria Jas, Dariusz Chlubek
APPLIED SCIENCES-BASEL (2021)
Impacts of bisphosphonates on the bone and its surrounding tissues: mechanistic insights into medication-related osteonecrosis of the jaw
Bhumrapee Srivichit, Chanisa Thonusin, Nipon Chattipakorn, Siriporn C. Chattipakorn
ARCHIVES OF TOXICOLOGY (2022)
Reporting Criteria for Clinical Trials on Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review and Recommendations
Camille Gaudet, Stephane Odet, Christophe Meyer, Brice Chatelain, Elise Weber, Anne-Laure Parmentier, Stephane Derruau, Sebastien Laurence, Cedric Mauprivez, Esteban Brenet, Halima Kerdjoudj, Mathilde Fenelon, Jean-Christophe Fricain, Narcisse Zwetyenga, David Hoarau, Remi Curien, Eric Gerard, Aurelien Louvrier, Florelle Gindraux
CELLS (2022)
A real-world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab
Paola Bracchi, Ernesto Zecca, Cinzia Brunelli, Rosalba Miceli, Gabriele Tine, Massimo Maniezzo, Silvia Lo Dico, Mariangela Caputo, Morena Shkodra, Augusto T. T. Caraceni
CANCER MEDICINE (2023)
Risk of Osteonecrosis of the Jaw Under Denosumab Compared to Bisphosphonates in Patients With Osteoporosis
Judith Everts-Graber, Daniel Lehmann, John-Patrik Burkard, Benoit Schaller, Brigitta Gahl, HansJoerg Haeuselmann, Ueli Studer, Hans-Rudolf Ziswiler, Stephan Reichenbach, Thomas Lehmann
JOURNAL OF BONE AND MINERAL RESEARCH (2022)
Assessment of Quality of Life in Patients with Medication-Related Osteonecrosis of the Jaw Following Reconstructive and Restorative Surgery
Kirill Arturovich Polyakov, Sofia Vladimirovna Popova, Liudmila Sergeevna Shamanaeva, Sergei Yurievich Ivanov, Pavel Sergeevich Petruk, Tatiana Petrovna Ivanyushko
APPLIED SCIENCES-BASEL (2021)
Management of medication-related osteonecrosis of jaw: Comparison between icariin and teriparatide in a rat model
Jie Liu, Nikos Mattheos, Chuanxi Deng, Cheng Su, Zekun Wang, Nanyu Luo, Hua Tang
JOURNAL OF PERIODONTOLOGY (2021)
Medication-Related Osteonecrosis of the Jaw in Cancer Patients: Result from the OneFlorida Clinical Research Consortium
Guang Yang, Roy Williams, Lishu Wang, Nosha Farhadfar, Yiqing Chen, Alexander T. Loiacono, Jiang Bian, Lexie Shannon Holliday, Joseph Katz, Yan Gong
JOURNAL OF BONE AND MINERAL RESEARCH (2022)
Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients
Sakiko Soutome, Mitsunobu Otsuru, Saki Hayashida, Maho Murata, Souichi Yanamoto, Shunsuke Sawada, Yuka Kojima, Madoka Funahara, Hiroshi Iwai, Masahiro Umeda, Toshiyuki Saito
SCIENTIFIC REPORTS (2021)
Multiple myeloma identified within the same site of the mandible with medication-related osteonecrosis of jaw: An unusual case report
Xiao-Hong Wu, Shi-Wei Chen
MEDICINE (2023)
A Phase II Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemoradiotherapy in the Adjuvant Setting in Operated Patients With HER2-positive Gastric or Gastroesophageal Junction Cancer (TOXAG Study) A Turkish Oncology Group Study
Huseyin Abali, Suayib Yalcin, Huseyin C. Onal, Faysal Dane, Berna Oksuzoglu, Nuriye Ozdemir, Huseyin Mertsoylu, Mehmet Artac, Celaletdin Camci, Bulent Karabulut, Fatma B. Basal, Burcin Budakoglu, Mehmet A. N. Sendur, Burce Goktas, Fatih Ozdener, Arzu Baygul
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2021)
Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment
Fatih Gurler, Aysegul Ilhan, Deniz Can Guven, Okan Turhan, Bediz Kurt Inci, Osman Sutcuoglu, Fatih Yildiz, Zafer Arik, Berna Oksuzoglu, Suayib Yalcin, Nuriye Ozdemir, Ozan Yazici, Ahmet Ozet
ANTI-CANCER DRUGS (2022)
The temporal evaluation of RAS and BRAF mutation by liquid biopsy at progression after bevacizumab combinations in patients with metastatic colorectal cancer (mCRC).
Irem Bilgetekin, Mehmet Dogan, Cengiz Karacin, Fatma Bugdayci Basal, Ece Esin, Gokhan Ucar, Ozlem Aydin Isak, Goksen Inanc Imamoglu, Gul Sema Yildiran Keskin, Ismail Erturk, Burak Yasin Aktas, Naziyet Kose Baytemur, Kubra Aydin, Selcuk Cemil Ozturk, Bulent Aksel, Nuri Karadurmus, Olcay Kandemir, Berna Oksuzoglu, Umut Demirci
JOURNAL OF CLINICAL ONCOLOGY (2021)
The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study
Emre Yekeduz, Deniz Tural, Ismail Erturk, Serdar Karakaya, Cihan Erol, Ozlem Ercelep, Cagatay Arslan, Ozlem Nuray Sever, Saadettin Kilickap, Nihan Senturk Oztas, Ahmet Kucukarda, Orcun Can, Berna Oksuzoglu, Mehmet Ali Sendur, Nuri Karadurmus, Yuksel Urun
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)
Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study
Tugba Basoglu, Abdullah Sakin, Cihan Erol, Ercan Ozden, Devrim cabuk, Ebru Cilbir, Deniz Tataroglu ozyukseler, Murat Ayhan, Mehmet Ali Sendur, Mutlu Dogan, Berna Oksuzoglu, Melek Karakurt Eryilmaz, Ozlem Er, Elif Senocak Tasci, Neslihan Ozyurt, Ozgecan Dulgar, Mirac Ozen, Ilhan Hacibekiroglu, Irem Oner, Esma Turkmen Bekmez, Hasan Cagri Yildirim, Suayib Yalcin, Semra Paydas, Emre Yekeduz, Asude Aksoy, Melike Ozcelik, Abdilkerim Oyman, Elvina Almuradova, Bulent Karabulut, Nazan Demir, Murat Dincer, Nuriye Ozdemir, Dilek Erdem, Naziye Ak, Ali Inal, Derya Kivrak Salim, Gulhan Ipek Deniz, Teoman Sakalar, Ahmet Gulmez, Turgut Kacan, Ozlem Ozdemir, Ozkan Alan, Caglar Unal, Yusuf Karakas, Serdar Turhal, Perran Fulden Yumuk
JOURNAL OF CHEMOTHERAPY (2023)
Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy A Prespecified Analysis of the monarchE Randomized Clinical Trial
Miguel Martin, Roberto Hegg, Sung-Bae Kim, Michael Schenker, Daniela Grecea, Jose Angel Garcia-Saenz, Konstantinos Papazisis, Quchang Ouyang, Aleksandra Lacko, Berna Oksuzoglu, James Reeves, Meena Okera, Laura Testa, Chikako Shimizu, Neelima Denduluri, Hryhoriy Adamchuk, Shaker Dakhil, Ran Wei, Tammy Forrester, Maria Munoz Fernandez, Annamaria Zimmermann, Desiree Headley, Stephen R. D. Johnston
JAMA ONCOLOGY (2022)
Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study
Mutlu Hizal, Burak Bilgin, Nail Paksoy, Saadettin Kilickap, Muhammed Mustafa Atci, Seda Kahraman, Merve Keskinkilic, Irem Bilgetekin, Murat Ayhan, Deniz Tural, Onder Eren, Fatma Nihan Akkoc Mustafayev, Sebnem Yaman, Ali Murat Tatli, Ertugrul Bayram, Yasin Kutlu, Ismail Erturk, Erkan Ozcan, Ahmet Gulmez, Mustafa Korkmaz, Baran Akagunduz, Dilek Erdem, Tugba Akin Telli, Asude Aksoy, Necdet Uskent, Yakup Iriagac, Naziyet Kose Baytemur, Dincer Aydin, Teoman Sakalar, Haci Arak, Fatih Selcukbiricik, Yakup Ergun, Taner Korkmaz, Naziye Ak, Caglar Unal, Nadiye Akdeniz, Mehmet Alpaslan Ozgun, Berna Oksuzoglu, Bulent Yalcin, Ilhan Oztop, Efnan Algin, Abdullah Sakin, Adnan Aydiner, Perran Fulden Yumuk, Mehmet Ali Nahit Sendur
FUTURE ONCOLOGY (2022)
The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors
Kadriye Bir Yucel, Emre Yekeduz, Serdar Karakaya, Deniz Tural, Ismail Erturk, Cihan Erol, Ozlem Ercelep, Nihan Senturk Oztas, Cagatay Arslan, Gokhan Ucar, Ahmet Kucukarda, Ozlem Nuray Sever, Saadettin Kilickap, Orcun Can, Sati Coskun Yazgan, Berna Oksuzoglu, Nuri Karadurmus, Mehmet Ali Sendur, Yuksel Urun
SCIENTIFIC REPORTS (2022)
Abemaciclib combined with adjuvant endocrine therapy in patients with high risk early breast cancer who received neoadjuvant chemotherapy (NAC)
Tjoung-Won Park-Simon, Miguel Martin, Roberto Hegg, Sung-Bae Kim, Michael Schenker, Daniela Grecea, Jose Angel Garcia-Saenz, Konstantinos Papazisis, Quchang Ouyang, Aleksandra Lacko, Berna Oksuzoglu, James Reeves, Meena Okera, Laura Testa, Chikako Shimizu, Ran Wei, Tammy Forrester, Maria Munoz, Annamaria Zimmermann, Desiree Headley, Stephen Johnston
ONCOLOGY RESEARCH AND TREATMENT (2022)
Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group)
Cihan Erol, Abdullah Sakin, Tugba Basoglu, Ercan Ozden, Devrim Cabuk, Mutlu Dogan, Berna Oksuzoglu, Hasan Cagri Yildirim, Irem Oner, Melek Karakurt Eryilmaz, Ozgecan Dulgar, Dincer Aydin, Neslihan Dogan, Mirac Ozen, Ilhan Hacibekiroglu, Nuriye Ozdemir, Fatih Gurler, Nail Paksoy, Senem Karabulut, Asude Aksoy, Mutlu Hizal, Seda Kahraman, Erdem Sen, Semra Paydas, Ebru Cilbir, Feyza Firat, Nadiye Akdeniz, Melike Ozcelik, Abdilkerim Oyman, Naziyet Kose Baytemur, Ramazan Acar, Elvina Almuradova, Bulent Karabulut, Teoman Sakalar, Haci Arak, Ezgi Degerli, Sema Turker, Ozkan Alan, Ozlem Er, Elif Senocak Tasci, Nazan Demir, Eyyup Cavdar, Serdar Turhal, Didem Sener Dede, Muhammed Bulent Akinci, Bulent Yalcin, Fulden Yumuk, Suayib Yalcin, Mehmet Ali Nahit Sendur
TURKISH JOURNAL OF MEDICAL SCIENCES (2022)
Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study).
Ahmet Bilici, Omer Fatih Olmez, Ahmet Sezer, Berna Oksuzoglu, Muhammet Ali Kaplan, Nuri Karadurmus, Erdem Cubukcu, Mehmet A. N. Sendur, Sercan Aksoy, Dilek Erdem, Gul Basaran, Burcu Cakar, Mesut Seker, Cagatay Arslan, Sema Sezgin Goksu, Irfan Cicin, Mahmut Gumus, Fatih Selcukbiricik, Hakan Harputluoglu, Kaan Helvaci
JOURNAL OF CLINICAL ONCOLOGY (2022)
Abemaciclib combined with adjuvant endocrine therapy in patients with high risk early breast cancer who received neoadjuvant chemotherapy (NAC).
Miguel Martin, Roberto Hegg, Sung-Bae Kim, Michael Schenker, Daniela Grecea, Jose A. Garcia-Saenz, Konstantinos Papazisis, Quchang Ouyang, Aleksandra Lacko, Berna Oksuzoglu, James Andrew Reeves, Meena Okera, Laura Testa, Chikako Shimizu, Ran Wei, Tammy D. Forrester, Maria Munoz, Annamaria H. Zimmermann, Desiree Headley, Stephen R. D. Johnston
JOURNAL OF CLINICAL ONCOLOGY (2021)
Adjuvant Chemoradiotherapy for Gastric Tumors with D2 Dissection: A Controversial Problem
Ibrahim Karadag, Serdar Karakaya, Ozturk Ates, Berna Cakmak Oksuzoglu
EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY (2021)
Enzalutamide versus Abiraterone Acetate as first-line treatment of castration resistant metastatic prostate cancer in geriatric (≥75) patients
Ali Alkan, Zeynep Gulsum Guc, Mustafa Gurbuz, Guliz ozgun, Serkan Degirmencioglu, Mutlu Dogan, Tugba Akin Telli, Ozge Keskin, Cagatay Arslan, Burak Bilgin, Sema Sezgin Goksu, Hacer Demir, Elif Berna Koksoy, Osman Kostek, Ismail Erturk, Teoman Sakalar, Arzu Yasar, Gorkem Turkkan, Bu ra Kasim, Aziz Karaoglu, Berna cakmak oksuzoglu, Fulden Yumuk, Mehmet Ali Sendur, Hasan Senol Coskun, Irfan cicin, Nuri Karadurmu, Ozgur Tanriverdi, Hakan Akbulut, Yuksel Urun
JOURNAL OF MENS HEALTH (2021)
A 5-Year Multicenter Clinical Experience in Local and Locally Advanced Nasopharyngeal Carcinoma from A Non-Endemic Region: A Retrospective Cohort Study
Ferit Aslan, Aysegul Ilhan, Fatih Yildiz, Havva Yesil Cinkir, Ayca Ant, Burcin Budakoglu, Berna Oksuzoglu
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI (2021)